AorticLab develops the FLOWer Embolic Protection Device, designed to capture debris during Transcatheter Aortic Valve Implantation (TAVI) procedures, thereby reducing the risk of embolic events. This device features a 60 µm mesh for secure anchoring in the aortic arch, enhancing patient safety and improving procedural outcomes.
Funding
$3.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Transcatheter Aortic Valve Implantation (TAVI) procedures carry a risk of releasing embolic debris into the bloodstream, potentially leading to strokes, kidney damage, and other adverse events affecting patient outcomes. Existing solutions may not provide complete protection against embolic events during TAVI.
Solution
AorticLab's FLOWer Embolic Protection Device is designed to capture embolic debris released during TAVI procedures, providing full-body protection. The device features a 60 µm mesh that securely anchors in the aortic arch, covering the brain, kidneys, and peripheral circulation. Its design allows for rapid and straightforward placement within the aortic arch, requiring minimal training for healthcare professionals. By capturing debris, the FLOWer device reduces the risk of embolic events, enhancing patient safety and improving procedural outcomes.
Target Audience
The primary target audience includes interventional cardiologists and cardiac surgeons performing TAVI procedures, as well as hospitals and cardiac centers focused on minimizing embolic complications and improving patient outcomes.
Features
- 60 µm mesh filter designed to capture a wide range of embolic debris.
- Secure anchoring mechanism ensures stable placement in the aortic arch throughout the TAVI procedure.
- Full-body protection covering the brain, kidneys, and peripheral circulation.
- Intuitive design facilitates rapid and straightforward deployment.